Challenges in MM

Chair(s)

• 

  Shaji Kumar, MD

  Professor of Medicine/Consultant
  Mayo Clinic, Rochester, MN, US
  Rochester, Minnesota, United States

Co-Chair(s)

• 

  Francesca Gay, MD

  Professor / Hematologist
  Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
  Torino, Piemonte, Italy

Presentations:

• 11:15 AM – 11:25 AM EEST

  Defining high risk and ultra-high risk MM
  

  Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital
• 11:25 AM – 11:35 AM EEST

  Molecular drivers of extramedullary progression
  

  Speaker: Moritz Binder, MD MPH (he/him/his) – Mayo Clinic
• 11:35 AM – 11:45 AM EEST

  Management of EMD and plasma cell leukemia
  

  Speaker: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
• 11:45 AM – 11:55 AM EEST

  Managing the older, frail patient with multiple co-morbidities
  

  Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
• 11:55 AM – 12:05 PM EEST

  OA-13: Increased levels of circulating tumor cells correlate with adverse clinical outcomes and distinct biological features in newly diagnosed patients with multiple myeloma
  

  Speaker: Ioannis V Kostopoulos, n/a – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece
• 12:05 PM – 12:15 PM EEST

  OA-40: Frailty and initial treatment intensity in patients newly diagnosed with multiple myeloma
  

  Speaker: Clark DuMontier, MD, MPH (he/him/his) – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School
• 12:15 PM – 12:25 PM EEST

  OA-39: Development and Validation of a Prognostic Survival Model with Patient Reported Outcomes for Older Adults with Multiple Myeloma
  

  Speaker: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
• 12:30 PM – 12:45 PM EEST

  Discuss abstracts in context
  

  Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
• 12:45 PM – 1:15 PM EEST

  Round table discussion
  

  Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS – National University Cancer Institute, Singapore

  Panelist: Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA

  Panelist: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada

  Panelist: Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC

  Panelist: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France